INTERNATIONAL PATENT: HANGZHOU ZHONGMEIHUADONG PHARMACEUTICAL CO., LTD., 杭州中美华东制药有限公司 FILES APPLICATION FOR "USE OF GLP-1R/GIPR DOUBLE-TARGET AGONIST IN PREPARING ANIMAL DRUG"

GENEVA, June 2 -- HANGZHOU ZHONGMEIHUADONG PHARMACEUTICAL CO., LTD. (No. 866, Moganshan Road, GongShu DistrictHangzhou, Zhejiang 310011), 杭州中美华东制药有限公司 (中国浙江省杭州市拱墅区莫干山路866号) filed a patent application (PCT/CN2024/133548) for "USE OF GLP-1R/GIPR DOUBLE-TARGET AGONIST IN PREPARING ANIMAL DRUG" on Nov 21, 2024. With publication no. WO/2025/108381, the details related to the patent application was published on May 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the ...